Heteroresistance Interdisciplinary Research Unit (Admin Core)
Heteroresistance Interdisciplinary Research Unit (Admin Core)
批准号:
10366034
负责人:
DAVID S WEISS
金额:
$35.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-05 至 2026-02-28
关键词:
AgreementAntibiotic ResistanceAwarenessCollaborationsCommunicationCommunitiesCommunity OutreachEnsureGoalsInfrastructureInstitutesInstitutionIntellectual PropertyInterdisciplinary StudyIntermediate resistanceInternationalLogisticsNational Institute of Allergy and Infectious DiseasePrevalenceProcessProperty RightsRecording of previous eventsResearchResearch PersonnelResearch Project GrantsStructureU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesbaseconflict resolutiondata managementdata sharingdesignmaterial transfer agreementmeetingsoperationprogramssymposium
中文摘要
摘要
行政核心的广泛目标是提供基础设施,使
异质电阻跨学科研究单位(HR-IRU),通过促进协同和生产性互动
在调查人员中。管理核心(核心A)对于帮助HR-IRU有效地满足其
长期目标是了解异质性抗性的机制基础、动态和流行程度。这个
核心的活动将由David Weiss博士和Bruce Levin博士领导,Dianne Miller女士和M.
珀尔·贝克曼。核心A的目标由五个具体目标定义,以及人员配置和管理
计划。这些目标将通过为各机构之间的业务后勤提供明确的结构来实现
以及该股的研究小组。HR-IRU由一个国际调查小组组成,具有强大的
富有成效的协作历史,并将促进持续的沟通和协同互动
调查人员中的研究项目和核心。核心A将实施并监督定期
视频会议、面对面会议和年度会议。已经为冲突开发了结构
决议、科学监督和通信后勤,以确保HR-IRU的有效运行。
HR-IRU的管理、协调和财务将在行政部门之间无缝运行
埃默里大学和乌普萨拉大学的办公室和研究小组。已经制定了保护
通过管理数据共享协议和互动来保护HR-IRU调查员的知识产权
HR-IRU的内部和外部。建立了一个定期沟通和透明的框架
HR-IRU和NIH/NIAID项目工作人员之间的关系,以及对NIH/NIAID请求的响应。
HR-IRU还旨在通过识别和寻找潜力来扩大异质电阻研究社区
HR-IRU调查人员与研究相关现象的外部研究人员之间的合作。
这包括埃默里大学和乌普萨拉大学社区内的广泛交流、外联
通过在会议和会议上展示研究结果以及邀请外部人员
科学专家参加联检组的年度会议。由行政部门实施的流程
核心和概述这五个目标建立在现有合作的基础上,以协调
高度跨学科的单位和更广泛的社区互动,以成功地使
在我们对异质电阻的理解中获得了基本的收获。
英文摘要
ABSTRACT
The broad objective of the Administrative Core is to provide infrastructure for the effective operation of the
Heteroresistance Interdisciplinary Research Unit (HR-IRU) by facilitating synergistic and productive interactions
amongst the investigators. The Administrative Core (Core A) is essential to help the HR-IRU efficiently meet its
long-term goal of understanding the mechanistic bases, dynamics, and prevalence of heteroresistance. The
activities of the Core will be led by Drs. David Weiss and Bruce Levin supported by Ms. Dianne Miller and Ms.
Pearl Backman. The goals of Core A are defined by five specific aims, along with Staffing and Management
Plans. The aims will be achieved by providing a defined structure for operational logistics between the institutions
and research groups in the Unit. The HR-IRU is comprised of an international team of investigators with a strong
history of productive collaboration, and will facilitate the continued communication and synergistic interactions
among the investigators in the research projects and cores. Core A will implement and oversee regular
videoconferences, face-to-face meetings, and annual meetings. Structures have been developed for conflict
resolution, scientific oversight, and communication logistics to ensure effective operation of the HR-IRU.
Management, coordination, and finances of the HR-IRU will operate seamlessly between the administrative
offices and research groups at Emory University and the University of Uppsala. Plans are in place to protect the
intellectual property rights of the HR-IRU investigators by managing data sharing agreements and interactions
internally and externally to the HR-IRU. A framework is in place for regular communication and transparency
between the HR-IRU and the NIH/NIAID program staff, and responsiveness to requests from the NIH/NIAID.
The HR-IRU also aims to broaden the heteroresistance research community by identifying and seeking potential
collaborations between HR-IRU investigators and external researchers studying related or relevant phenomena.
This includes broad communications within Emory University and University of Uppsala communities, outreach
to researchers through presentation of findings at meetings and conferences, and invitation of an external
scientific expert to participating the Unit's annual meetings. The processes implemented by the Administrative
Core and outlined by these five aims build upon existing collaborations to coordinate the smooth operation of
the highly interdisciplinary Unit and interactions broader community, in order to be successful in making
fundamental gains in our understanding of heteroresistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10366038
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
-
批准号:10369416
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
-
批准号:10518406
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10583505
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10170971
-
项目类别:
-
资助金额:$56.46万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Admin Core)
-
批准号:10170967
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Admin Core)
-
批准号:10583498
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10646392
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10206015
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10053046
-
项目类别:
-
资助金额:$82.33万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10433990
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria
-
批准号:9790937
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Peptidoglycan binding protein specificity and bacterial cell division
-
批准号:10015285
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria
-
批准号:10242729
-
项目类别:
-
资助金额:$43.47万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Peptidoglycan binding protein specificity and bacterial cell division
-
批准号:10246987
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii
-
批准号:9205452
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR/Cas systems in bacterial gene regulation and virulence
-
批准号:8671666
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2014
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR/Cas systems in bacterial gene regulation and virulence
-
批准号:8793757
-
项目类别:
-
资助金额:$44.12万
-
财政年份:2014
-
负责人:DAVID S WEISS
-
依托单位:
Molecular Characterization of Francisella tularensis SchuS4 virulence factors
-
批准号:8375877
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2012
-
负责人:DAVID S WEISS
-
依托单位:
ArmR: a novel drug target and mediator of antibiotic resistance
-
批准号:8268754
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2012
-
负责人:DAVID S WEISS
-
依托单位:
海外基金